Companies › KYTX

KYVERNA THERAPEUTICS INC (KYTX)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001994702 · EDGAR filings · Updated 2026-07-27

KYVERNA THERAPEUTICS INC (KYTX) has reported institutional ownership of 57.6%, with 111 institutional managers holding positions valued at $300.5M per the latest 13F reporting period.

Filings this week (1)

• 2026-07-27 — Current report (8-K) filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-09 — Current report (8-K) filed
• 2026-06-02 — Current report (8-K) filed
• 2026-05-29 — Insider transaction reported (Form 4)
• 2026-05-29 — Insider transaction reported (Form 4)
• 2026-05-29 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, KYVERNA THERAPEUTICS INC has 111 institutional holders and institutional ownership of 57.6%.

Insider activity

Insiders reported 19 transactions (2 buys, 1 sells) across 14 reporting insiders, with a net reported value of $1.71M.

Related companies

CENTURY THERAPEUTICS INC (IPSC) · LUMEXA IMAGING HOLDINGS INC (LMRI) · LENZ THERAPEUTICS INC (LENZ) · AQUESTIVE THERAPEUTICS INC (AQST) · INVIVYD INC (IVVD) · FULGENT GENETICS INC (FLGT)